Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

by | Dec 18, 2025 | Clinical Trials | 0 comments

​ Conditions: Oropharyngeal Cancer

Interventions: Drug: Toripalimab; Drug: Carboplatin; Drug: Paclitaxel

Sponsors: University of Chicago

Not yet recruiting Conditions: Oropharyngeal Cancer
Interventions: Drug: Toripalimab; Drug: Carboplatin; Drug: Paclitaxel
Sponsors: University of Chicago
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *